Use of bioavailability data by practitioners. I: pitfalls in interpreting the data

Potential pitfalls in evaluating bioavailibility data are presented. These pitfalls are involved with interpretation of the therapeutic significance of the data, the methodology of the bioavailibility study and presentation of data. Specific information which should be requested from manufacturers for proper evaluation of bioavailibility data is given.